Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ferulamide (4-Hydroxy-3-methoxycinnamide), a Ferulic acid derivative, shows potent inhibitory activity against arachidonic acid-induced platelet aggregation.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 185.00 | |
5 mg | In stock | $ 455.00 | |
10 mg | In stock | $ 669.00 | |
25 mg | In stock | $ 1,050.00 | |
50 mg | In stock | $ 1,420.00 | |
100 mg | In stock | $ 1,920.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 391.00 |
Description | Ferulamide (4-Hydroxy-3-methoxycinnamide), a Ferulic acid derivative, shows potent inhibitory activity against arachidonic acid-induced platelet aggregation. |
In vitro | A series of Ferulamide derivatives were prepared and evaluated for their anti-platelet activities. Some of these compounds showed potent inhibitory activity against arachidonic acid-induced platelet aggregation. Their structure-activity relationships are also discussed[1]. |
Source |
Synonyms | 4-Hydroxy-3-methoxycinnamide |
Molecular Weight | 193.2 |
Formula | C10H11NO3 |
CAS No. | 61012-31-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (258.8 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ferulamide 61012-31-5 GPCR/G Protein Neuroscience AChR PAFR inhibit 4-Hydroxy-3-methoxycinnamide nAChR Inhibitor Ferulic Nicotinic acetylcholine receptors anticholinesterase acid inhibitor